mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.8 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |
mRNA |
Gefitinib |
FIMM |
pan-cancer |
AAC |
-0.032 |
0.8 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.8 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.8 |
mRNA |
Panobinostat |
FIMM |
pan-cancer |
AAC |
0.023 |
0.8 |